JNJ vs DVA
By Alex · Tickerpine
Johnson & Johnson vs DaVita Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | DVA |
|---|---|---|
| Price | $254.66 | $217.04 |
| Market cap | $613.02B | $13.93B |
| P/E ratio | 29.5 | 20.9 |
| ROE | 26.42% | 80.98% |
| Profit margin | 21.83% | 5.65% |
| Revenue growth | 9.90% | 6.00% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.91 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs DVA in plain English
- JNJ is the bigger company — about 44.0× the market cap of DVA.
- DVA is cheaper on earnings (P/E 20.9 vs 29.5).
- DVA earns a higher return on equity (81% vs 26%).
- JNJ is growing revenue faster (10% vs 6%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
DVA return calculator
See what $1,000 in DaVita Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.